Bio-Rad Labs (BIO) Misses Q2 EPS by 52c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $379.99 --0%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
KEEL, SENEA, XFOR, More
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
KEEL, SENEA, XFOR, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $0.61, $0.52 worse than the analyst estimate of $1.13. Revenue for the quarter came in at $516.8 million versus the consensus estimate of $497.8 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verisk Analytics (VRSK) Tops Q3 EPS by 3c; Offers Guidance
- CareCloud, Inc. (CCLD) Reports In-Line Q3 EPS
- Nova Measuring Instruments (NVMI) Tops Q3 EPS by 9c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
